The nation’s hospital industry says prescription costs are busting budgets with costs per inpatient admission jumping nearly 40% between 2013 and 2015 .
A new analysis unveiled by the industry’s two biggest lobbies – the American Hospital Association and the Federation of American Hospitals – is the latest salvo in an escalating battle in Washington over prescription drug costs. Lately, drug makers like Mylan deflect price hikes for the EpiPen on pharmacy benefit managers while PBMs and insurers point fingers at the pharmaceutical industry. Hospitals are now entering the fray with a University of Chicago analysis showing large price increases in just a short time on medicines that have generally been around for years such as drugs used during surgery or anesthesia.
